Nausea and vomiting of pregnancy (NVP( are common conditions with 50–80% prevalence for nausea and 50% vomiting (ACOG, 2018). Nausea has been reported to be responsible for 33% of all sick leave during pregnancy (Gray et al., 2018). NVP can significantly reduce pregnant women's quality of life and negatively affect daily activities, relationships with partners, parenting, occupation, and social functioning (Bustos et al., 2017, Gray et al., 2018). Studies have also highlighted the economic burden on women and society, mainly due to lost productivity and healthcare costs (ACOG, 2018, Gray et al., 2018, Matthews et al., 2015). In a cross-sectional multinational web-based study of 9113 pregnant women and new mothers, 73.5% experienced nausea during pregnancy (Heitmann et al., 2015). Despite its high prevalence and the resulting social and economic problems, its definitive treatment has not been determined (Schrager et al., 2021).
There is little data on safety concerning risks of structural malformations for many medications (Parker et al., 2018). The teratogenic effects of using some drugs to control these symptoms have led to cautious prescribing and taking medications in the first trimester (Matthews et al., 2015). Most women preferred not to take medications, especially out of concern for these drugs’ side effects on the fetus (Gray et al., 2018). In one study, the respondents with nausea were administered standard medications and medicinal plants in 17.9% and 8.3%, respectively (Heitmann et al., 2015).
Psychological conditions during gestation and their impact on perinatal outcomes are a matter of debate. However, one of the most prevalent conditions is anxiety, affecting approximately one-third of pregnant women at some point during gestation (Ravid et al., 2018). A large meta-analysis of 102 studies found a prevalence of antenatal anxiety ranging from 18.2% in the first trimester to 24.6% in the third trimester (Dennis et al., 2017). Anxiety may increase the risk of preterm birth and low birth weight infants (Dennis et al., 2017, Ravid et al., 2018). In addition, in a study conducted in the Netherlands, antenatal anxiety early in pregnancy significantly increased the risk for cognitive disorders in children at 14 and 15 years of age (Dennis et al., 2017).
Consequently, many women may turn to complementary and alternative medicine (CAM) as a natural and safe method to alleviate their symptoms (Heitmann et al., 2015). The prevalence of complementary and alternative medicine (CAM) use in pregnancy has been reported to range between 20% and 60% (Di Vito et al., 2021). Aromatherapy is one of the most popular CAM used by pregnant women (Di Vito et al., 2021) that uses essential oils to maintain and promote physical, psychological, and spiritual well-being (Ali et al., 2015, Hedaoo et al., 2019). Lavender oil has been introduced as the most often used oil at each trimester of pregnancy (0.7%, 0.6%, and 0.3%, respectively) (Bishop et al., 2011).
The positive effects of aromatherapy with Lavender on post-operative’s nausea and vomiting (PONV) (Karaman et al., 2019), also after chemotherapy in patients with breast cancer have been reported (Ain et al., 2019). However, the Lavender had no significant effect on nausea after percutaneous nephrolithotomy (Amirhosseini et al., 2020). Using a combination of Lavender, Peppermint, Spearmint, and Ginger oil significantly affected PONV (Hodge et al., 2014). The study of the effect of only Lavender on NVP is limited. In one study, Lavender oil was more effective than Ginger aromatherapy (Rahayu & Sugita, 2018). In another, Peppermint and Lavender’s combination therapy reduced the severity of NVP, increased energy levels, and reduced fatigue in pregnant women (Ghani & Ibrahim, 2013). The limitation of studies indicates the need for further research to definitive conclusions about the impact of Lavender aroma on NVP.
Lavender is one of the most popular essential oils for mental disorders and anxiety (López et al., 2017). Some researchers reported the positive effect of Lavender oil in anxiety conditions; dental anxiety (Arslan et al., 2020), bone marrow biopsy (Abbaszadeh et al., 2020), peripheral venous cannulation (Karaman et al., 2016), reduction of cortisol level in candidates for open-heart surgery (Hosseini et al., 2016), in high-risk postpartum women (Conrad & Adams, 2012), postpartum blues (Amin et al., 2020), also during labor (Mirzaei et al., 2009). The results of a Systematic Review and Meta-analysis of randomized controlled trials showed that aromatherapy with Lavender might have positive effects on anxiety and its physiological manifestations (Kang et al., 2019).
The study of the effect of only Lavender on the anxiety of pregnancy is limited. In two studies, Lavender oil was one of the three possible oils to choose for inhalation in pregnancy (Igarashi and Fujita, 2010, Igarashi, 2013). One study evidence that aromatherapy massage with Lavender oil could significantly decrease stress and enhance immune function in pregnant women (Chen et al., 2017). Moreover, one study has reported that aromatherapy inhalation with foot-bath and Lavender alone could significantly decrease anxiety in pregnancy (Effati-Daryani et al., 2015).
Various researchers reported the association between anxiety with nausea and vomiting during pregnancy (Köken et al., 2008, Nikibakhsh et al., 2016, Beyazit et al., 2018); however, in a randomized control trial, the Mint oil positively reduced nausea and vomiting during pregnancy without any impact on state anxiety (Amzajerdi et al., 2019).
According to the Cochrane review, there is little evidence that non-pharmacological methods effectively reduced the NVP (Matthews et al., 2015). As a result, more studies need to approve this method as an effective method for pregnant women. The present study was designed to investigate the effects of a one-week Lavender oil on NVP and anxiety. It was; based on the hypothesis that Lavender improves nausea, vomiting, and anxiety in pregnancy.